ResearcherProvidence Portland Medical CenterNo recent work listed

Rom S. Leidner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0788-7938; OpenAlex author ID A5064621435. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 2 papers

Papers 2

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. Reply. Last author DOI 10.1056/nejmc2208623 ↗
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2119662 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eric Tran · 2 shared papers, 2022 · strength 0.39
- Paper Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. Reply. DOI 10.1056/nejmc2208623 ↗
- Paper Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. DOI 10.1056/nejmoa2119662 ↗
Steven Rosenberg · 1 shared paper, 2022 · strength 0.13
- Paper Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. DOI 10.1056/nejmoa2119662 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.